A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma-Reference-Cited by-同舟云学术

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma

Published:2002-08 Issue:8 Volume:13 Page:1185-1191
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ducreux M.,Rougier P.,Pignon J.-P.,Douillard J.-Y.,Seitz J.-F.,Bugat R.,Bosset J.-F.,Merouche Y.,Raoul J.-L.,Ychou M.,Adenis A.,Berthault-Cvitkovic F.,Luboinski M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/8/1185/333446/mdf197.pdf

Reference27 articles.

1. Estimates of the worldwide mortality from 25 cancers in 1990;Pisani;Int J Cancer,1999

2. Cancer incidence and mortality in France in 1975–95;Menegoz;Eur J Cancer Prev,1997

3. Incidence, diagnostic, traitement et pronostic du cancer du pancréas: évolution en Côte-d’Or de 1976 à 1985;Moutet;Bull Cancer Paris,1991

4. Treatment and survival in 13 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study;Bramhall;Br J Surg,1995

5. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients;Yeo;Ann Surg,1995

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapie des metastasierten Pankreaskarzinoms;Springer Reference Medizin;2024

2. Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study;BMC Cancer;2023-11-07

3. Stem cell factor modulates HIF‐1α levels and diminishes 5‐FU sensitivity in 5‐FU resistant pancreatic cells by altering the anabolic glucose metabolism;Journal of Biochemical and Molecular Toxicology;2023-09-17

4. S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL;Zeitschrift für Gastroenterologie;2022-11

5. Systemic Therapy for Metastatic Pancreatic Cancer;Current Treatment Options in Oncology;2021-10-19